Condition: Peritoneal Dialysis · Diabetes · Sponsor: The People's Hospital of Gaozhou
The study is a single center, open, prospective, self controlled clinical study. The patients with diabetes who are to be enrolled in peritoneal dialysis are to observe the changes of glycosylated hemoglobin relative to the baseline 90 days after using amino acid (15) peritoneal dialysis solution.
This description comes directly from the study's public registry record.
Shanshan Deng · 8613927596600 · 276531255@qq.com
Always discuss trial participation with your own doctor first.
| Medical Ethics Committee of Gaozhou People's Hospital | Gaozhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07077538